Katodritou E, Terpos E, Kelaidi C, Kotsopoulou M, Delimpasi S, Kyrtsonis M-C, Symeonidis A, Giannakoulas N, Stefanoudaki A, Christoulas D, et al. Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group. American Journal of Hematology [Internet]. 2014;89(2):145 - 150.